Joseph P. Hagan serves as Executive at Orexigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joseph P. Hagan has executed 51 insider transactions totaling $2.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 27, 2012 involved selling 30,000 shares valued at $165.0K.
Joseph P. Hagan currently holds 57,112 shares of Orexigen Therapeutics, Inc. (OREX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph P. Hagan has been a net seller of OREX stock. They have purchased $353.2K and sold $2.2M worth of shares.
Joseph P. Hagan's most recent insider trade was on Jun 27, 2012, when they sold 30,000 shares at $5.50 per share.
Get notified when new Form 4 filings are submitted